{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T03:17:52Z","timestamp":1774408672743,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","immunology.theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology and Allergy Clinics of North America"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.iac.2016.06.003","type":"journal-article","created":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T19:23:55Z","timestamp":1473881035000},"page":"657-668","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Diagnostic Evaluation in Aspirin-Exacerbated Respiratory Disease"],"prefix":"10.1016","volume":"36","author":[{"given":"Adam N.","family":"Williams","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.iac.2016.06.003_bib1","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.jaci.2014.08.020","article-title":"Prevalence of aspirin-exacerbated respiratory disease among asthmatic patients: a meta-analysis of the literature","volume":"135","author":"Rajan","year":"2014","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.003_bib2","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1034\/j.1399-3003.2000.016003432.x","article-title":"Natural history of aspirin-induced asthma","volume":"16","author":"Szczeklik","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.iac.2016.06.003_bib3","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1081-1206(10)60465-6","article-title":"Predicting outcomes of oral aspirin challenges in patients with asthma, nasal polyps, and chronic sinusitis","volume":"100","author":"Dursun","year":"2008","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2016.06.003_bib4","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S1081-1206(10)60012-9","article-title":"Intranasal ketorolac challenge for the diagnosis of aspirin exacerbated respiratory disease","volume":"97","author":"White","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2016.06.003_bib5","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.anai.2010.05.020","article-title":"Use of intranasal ketorolac and modified oral aspirin challenge for desensitization of aspirin-exacerbated respiratory disease","volume":"105","author":"Lee","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2016.06.003_bib6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.iac.2012.10.002","article-title":"Aspirin-exacerbated respiratory disease: clinical disease and diagnosis","volume":"33","author":"Bochenek","year":"2013","journal-title":"Immunol Allergy Clin N Am"},{"key":"10.1016\/j.iac.2016.06.003_bib7","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1034\/j.1399-3003.2000.15e09.x","article-title":"Oral and bronchial provocation tests with aspirin for diagnosis of aspirin-induced asthma","volume":"15","author":"Nizankowska","year":"2000","journal-title":"Eur Respir J"},{"key":"10.1016\/j.iac.2016.06.003_bib8","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1183\/09031936.93.03050527","article-title":"Comparison of bronchial and per oral provocation with aspirin in aspirin-sensitive asthmatics","volume":"3","author":"Dahlen","year":"1990","journal-title":"Eur Respir J"},{"key":"10.1016\/j.iac.2016.06.003_bib9","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0091-6749(98)70163-0","article-title":"Nasal provocation test for diagnosis of aspirin-induced asthma","volume":"101","author":"Milewski","year":"1998","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.003_bib10","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1034\/j.1398-9995.2002.t01-1-13447.x","article-title":"Nasal provocation test (NPT) with aspirin: a sensitive and safe method to diagnose aspirin-induced asthma (AIA)","volume":"57","author":"Alonso-Llamazares","year":"2002","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2016.06.003_bib11","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2500\/ajra.2011.25.3591","article-title":"The nose as a target organ in the diagnosis of severe aspirin-exacerbated respiratory disease","volume":"25","author":"Gonzalez-Perez","year":"2011","journal-title":"Am J Rhinol Allergy"},{"key":"10.1016\/j.iac.2016.06.003_bib12","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.anai.2013.07.009","article-title":"Use of nasal inspiratory flow rates in the measurement of aspirin-induced respiratory reactions","volume":"111","author":"Celikel","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2016.06.003_bib13","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1398-9995.2007.01409.x","article-title":"EAACI\/GA2LEN guideline: aspirin provocation tests for diagnosis of aspirin hypersensitivity","volume":"62","author":"Nizankowska-Mogilnicka","year":"2007","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2016.06.003_bib14","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/S1081-1206(10)60692-8","article-title":"Aspirin challenge and desensitization for aspirin-exacerbated respiratory disease: a practice paper","volume":"98","author":"Macy","year":"2007","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2016.06.003_bib15","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.iac.2012.10.013","article-title":"Aspirin desensitization in AERD","volume":"33","author":"White","year":"2013","journal-title":"Immunol Allergy Clin N Am"},{"key":"10.1016\/j.iac.2016.06.003_bib16","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S1081-1206(10)61150-7","article-title":"The blocking effect of essential controller medications during aspirin challenges in patients with aspirin-exacerbated respiratory disease","volume":"95","author":"White","year":"2005","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2016.06.003_bib17","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1136\/thx.34.5.654","article-title":"Inhibition of idiosyncratic reactions to aspirin in asthmatic patients by clemastine","volume":"34","author":"Szczeklik","year":"1979","journal-title":"Thorax"},{"key":"10.1016\/j.iac.2016.06.003_bib18","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1164\/ajrccm\/148.6_Pt_1.1447","article-title":"The pivotal role of 5-lipoxygenase products in the reaction of aspirin-sensitive asthmatics to aspirin","volume":"148","author":"Israel","year":"1993","journal-title":"Am Rev Respir Dis"},{"key":"10.1016\/j.iac.2016.06.003_bib19","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S1081-1206(10)62575-6","article-title":"Montelukast is only partially effective in inhibiting aspirin responses in aspirin-sensitive asthmatics","volume":"85","author":"Stevenson","year":"2000","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2016.06.003_bib20","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/S1081-1206(10)61101-5","article-title":"Effect of leukotriene modifier drugs on the safety of oral aspirin challenges","volume":"97","author":"White","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2016.06.003_bib21","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2500\/aap.2013.34.3670","article-title":"The clinical dilemma of \u2018\u2018silent desensitization\u2019\u2019 in aspirin-exacerbated respiratory disease","volume":"34","author":"White","year":"2013","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.iac.2016.06.003_bib22","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1046\/j.1365-2745.2002.01501.x","article-title":"The effect of leukotriene-modifier drugs on aspirin-induced asthma and rhinitis reactions","volume":"32","author":"Berges-Gimeno","year":"2002","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.iac.2016.06.003_bib23","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1159\/000354543","article-title":"World Allergy Organization Anaphylaxis Guidelines: 2013 update of the evidence base","volume":"162","author":"Simons","year":"2013","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.iac.2016.06.003_bib24","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/all.12318","article-title":"Management of anaphylaxis: a systematic review","volume":"69","author":"Dhami","year":"2014","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2016.06.003_bib25","first-page":"129","article-title":"Aspirin induced tolerance in aspirin-induced asthma detected by a new challenge test","volume":"5","author":"Bianco","year":"1977","journal-title":"J\u00a0Med Sci"},{"key":"10.1016\/j.iac.2016.06.003_bib26","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jaci.2007.09.039","article-title":"Systemic responses after bronchial aspirin challenge in sensitive patients with asthma","volume":"121","author":"Makowska","year":"2008","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.003_bib27","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1111\/cea.12110","article-title":"Nasal lysine aspirin challenge in the diagnosis of aspirin-exacerbated respiratory disease","volume":"43","author":"Miller","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.iac.2016.06.003_bib28","first-page":"273.e1-e78","article-title":"Drug allergy: an updated practice parameter","volume":"105","author":"Joint Task Force on Practice Parameters","year":"2010","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.iac.2016.06.003_bib29","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.jaip.2015.06.013","article-title":"An hourly dose-escalation desensitization protocol for aspirin-exacerbated respiratory disease","volume":"3","author":"Chen","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.iac.2016.06.003_bib30","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.jaci.2006.06.019","article-title":"Selection of patients for aspirin desensitization treatment","volume":"118","author":"Stevenson","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.003_bib31","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jaci.2008.09.048","article-title":"Rational approach to aspirin dosing during oral challenges and desensitization of patients with aspirin-exacerbated respiratory disease","volume":"123","author":"Hope","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.003_bib32","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.jaci.2007.03.020","article-title":"The relationship between historical aspirin-induced asthma and severity of asthma induced during oral aspirin challenges","volume":"120","author":"Williams","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.003_bib33","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1398-9995.2011.02557.x","article-title":"Hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs)\u2013classification, diagnosis and management: review of the EAACI\/ENDA and GA2LEN\/HANNA","volume":"66","author":"Kowalski","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2016.06.003_bib34","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000176307","article-title":"Cellular allergen stimulation test with acetylsalicylic acid-lysine is not a useful test to discriminate between asthmatic patients with and without acetylsalicylic acid sensitivity","volume":"149","author":"Bavbek","year":"2009","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.iac.2016.06.003_bib35","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1046\/j.1365-2222.2001.01074.x","article-title":"Release of cysteinyl leukotrienes with aspirin stimulation and the effect of prostaglandin E(2) on this release from peripheral blood leucocytes in aspirin-induced asthmatic patients","volume":"31","author":"Celik","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.iac.2016.06.003_bib36","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1046\/j.1365-2222.2000.00953.x","article-title":"A\u00a0moderate and unspecific release of cysteinyl leukotrienes by aspirin from peripheral blood leucocytes precludes its value for aspirin sensitivity testing in asthma","volume":"30","author":"Pierzchalska","year":"2000","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.iac.2016.06.003_bib37","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000082586","article-title":"A\u00a0new combined test with flowcytometric basophil activation and determination of sulfidoleukotrienes is useful for in\u00a0vitro diagnosis of hypersensitivity to aspirin and other non-steroidal anti-inflammatory drugs","volume":"136","author":"Sanz","year":"2005","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.iac.2016.06.003_bib38","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1111\/j.1365-2222.2004.02050.x","article-title":"The flow-cytometric determination of basophil activation induced by aspirin and other non-steroidal anti-inflammatory drugs (NSAIDs) is useful for in\u00a0vitro diagnosis of the NSAID hypersensitivity syndrome","volume":"34","author":"Gamboa","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.iac.2016.06.003_bib39","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/ACI.0b013e32832d5311","article-title":"Basophil activation tests in the evaluation of immediate drug hypersensitivity","volume":"9","author":"Sanz","year":"2009","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.iac.2016.06.003_bib40","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1111\/j.1398-9995.2005.00836.x","article-title":"Aspirin-triggered 15-HETE generation in peripheral blood leukocyte is specific and sensitive Aspirin-Sensitive Patients Identification Test (ASPITest)","volume":"60","author":"Kowalski","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.iac.2016.06.003_bib41","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1111\/j.1365-2222.2008.02989.x","article-title":"Involvement of 15-lipoxygenase and prosta-glandin EP receptors in aspirin-triggered 15-hydroxyeicosatetraenoic acid generation in aspirin-sensitive asthmatics","volume":"38","author":"Jedrzejczak-Czechowicz","year":"2008","journal-title":"Clin\u00a0Exp Allergy"}],"container-title":["Immunology and Allergy Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856116300480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0889856116300480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T03:33:40Z","timestamp":1692502420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0889856116300480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S0889856116300480"],"URL":"https:\/\/doi.org\/10.1016\/j.iac.2016.06.003","relation":{},"ISSN":["0889-8561"],"issn-type":[{"value":"0889-8561","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnostic Evaluation in Aspirin-Exacerbated Respiratory Disease","name":"articletitle","label":"Article Title"},{"value":"Immunology and Allergy Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.iac.2016.06.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}